Peptide Based Cardiovascular Therapeutics Market Forecast Report Based on Global Health Industry Size, Trends and CAGR Rate through 2017 to 2022

Dublin, Ireland, 2018-Jul-24 — Global peptide based cardiovascular therapeutics market is exhibiting excellent growth. As the manufacturers are developing new methods for the development of novel peptides that are used in curing of cardiovascular disorders with decreasing cost, this market is showing a positive trajectory. This FactMR report analyzes the expansion of global Peptide Based Cardiovascular Therapeutics Market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

The scope of FactMR’s report is to analyze the global peptide based cardiovascular therapeutics market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Peptide based cardiovascular therapeutics providers, research institutes and key players in the global peptide based cardiovascular therapeutics market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to peptide based cardiovascular therapeutics.

Request for Sample Report on Peptide Based Cardiovascular Therapeutics Market – https://www.factmr.com/connectus/sample?flag=S&rep_id=191

This FactMR report on the global peptide based cardiovascular therapeutics market forecasts that the global peptide based cardiovascular therapeutics market will touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

Cardiovascular disease is the leading cause of mortality and morbidity all over the world. In the past, the development of peptides as therapeutic agents had been avoided by pharmaceutical industry due to their low stability, rate of degradation and poor delivery. However, in recent times, resurgence has taken place in the field of peptides as therapeutics. Economic factors such as increasing healthcare expenditure and increasing FDI in emerging economies are expected to drive the market of peptide based cardiovascular therapeutics. Additionally, increasing prevalence of cardiovascular disorders, emergence of prominent pharmaceutical and biotech companies and strong R&D in the development of new peptides are fuelling the market growth. However, various factors such as increasing costs of commercialization, rapid metabolism of peptide drugs and regulatory conditions are expected to hamper market growth.

Therapeutic peptides are used in the treatment of cardiovascular disorders that are a leading cause of mortality and morbidity throughout the world. Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. Such type of covalent chemical bonds are formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are differentiated from proteins on the basis of size, and peptides contain 50 amino acids or less approximately.

The market in North America is set to dominate the global peptide based cardiovascular therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based cardiovascular therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.

As per the forecast of FactMR, the bivalirudin segment is expected to reach a value of nearly US$ 1,360 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Bivalirudin segment is expected to account for more than two-third of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.

To know the Latest Trends in Peptide Based Cardiovascular Therapeutics Market, Visit Here – https://www.factmr.com/report/191/peptide-based-cardiovascular-therapeutics-market

As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 960 Mn in the year 2022. This represents a CAGR of 8.9% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global peptide based cardiovascular therapeutics market through 2022, which include AstraZeneca, plc, Corden Pharma GmbH, Ipsen S.A, Merck & Co., Inc., Pfizer Inc, Apotex Holdings, Inc., Dr. Reddy’s Laboratories Limited, Fresenius Kabi USA, LLC, Novetide Ltd and Amneal Pharmaceuticals LLC.

Table of Contents

1. Global Peptide Based Cardiovascular Therapeutics Market – Executive Summary
2. Global Peptide Based Cardiovascular Therapeutics Market Overview

2.1. Introduction

2.1.1. Global Peptide Based Cardiovascular Therapeutics Market Taxonomy

2.1.2. Global Peptide Based Cardiovascular Therapeutics Market Definition

2.2. Global Peptide Based Cardiovascular Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022

2.2.1. Global Peptide Based Cardiovascular Therapeutics Market Y-o-Y Growth

2.3. Global Peptide Based Cardiovascular Therapeutics Market Dynamics

2.4. Regulations

2.5. Supply Chain

2.6. Cost Structure

2.7. Average Pricing Analysis

2.8. Epidemiology

2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Peptide Based Cardiovascular Therapeutics Market Analysis and Forecast By Drug

3.1. Global Peptide Based Cardiovascular Therapeutics Market Size and Forecast By Drug, 2012-2022

3.1.1. Bivalirudin Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022

3.1.1.1. Revenue (US$ Mn) Comparison, By Region

3.1.1.2. Market Share Comparison, By Region

3.1.1.3. Y-o-Y growth Comparison, By Region

3.1.2. Eptifibatide Peptide Based Cardiovascular Therapeutics Market Size and Forecast, 2012-2022

3.1.2.1. Revenue (US$ Mn) Comparison, By Region

3.1.2.2. Market Share Comparison, By Region

3.1.2.3. Y-o-Y growth Comparison, By Region

Continued………………………

To Buy Global Market Research Report, Check here – https://www.factmr.com/checkout/191/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Sports market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us –

FactMR
Suite 9884
27 Upper Pembroke Street, Dublin 2, Ireland
Telephone @ +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/